Research Highlights

Current Research Highlights

Revising Medicare Part D Prescription Drug Policy Could Save Billions

October 7, 2024

Removing protected class regulation from Medicare prescription drug policies could greatly reduce the United States' prescription drug spending—this could have saved potentially $47 billion between 2011-2019, according to Weill Cornell Medicine researchers.

The study, published Oct. 7 in Health Affairs,...

Read More
Highlights

Racial and Ethnic Disparities in Take-Home Methadone Use for Medicare Beneficiaries With Opioid Use Disorder

September 16, 2024

In 2020, as a response to the significant increase in opioid overdose deaths over the past decade, Medicare initiated coverage of methadone treatment for opioid use disorder (OUD), including take-home dosing. The Substance...

Read More
Highlights
Photos of Dr. Hye-Young Jung, medication, and a Medicare card

Analysis Could Guide the Future of Telehealth Policies

September 4, 2024

In a first-of-its-kind study, Weill Cornell Medicine researchers found that female physicians, primary care physicians, psychiatrists and physicians in non-rural areas delivered relatively higher proportions of visits via telehealth. This national analysis may provide key information for policymakers to consider as COVID-19 provisions for expanded Medicare telehealth coverage are set to expire at the end of this year.

...
Read More
Highlights

Views of ACO Leaders on Meeting the Needs of Socially Vulnerable Patients

August 6, 2024

Accountable care organizations (ACOs) are groups of health care practitioners and institutions responsible for the quality and cost of care for their attributed patients. Although ACOs are among Medicare’s most prominent value-based payment efforts, there is limited research on whether or...

Read More
Highlights
Photos of Dr. Dhruv Khullar, Dr. Amelia Bond, a Medicare card, and a group of physicians

Population Health Sciences 402 E. 67th St. New York, NY 10065 Phone: (646) 962-8001